PMS to Evaluate the Safety and Efficacy of Picato® Gel
Status:
Completed
Trial end date:
2018-01-19
Target enrollment:
Participant gender:
Summary
This study is a mandatory post launch observational study in South Korea of 3.000 patients
receiving treatment for the first time with a new medicinal product, ingenol mebutate gel
(Picato®), approved for topical treatment of actinic keratosis.
Each patient is observed for 8 weeks after treatment completion.